Jackson Lab acquires New York Stem Cell Foundation to leverage biomedical data
MaineBiz Jackson Lab acquires New York Stem Cell Foundation to leverage biomedical data By Laurie Schreiber Jackson Laboratory, a genetics and genomic medicine organization headquartered in Bar Harbor, completed its acquisition of the New York Stem Cell Foundation, a nonprofit that developed an AI platform that supports large amounts of data related to stem cell research. Lon Cardon, the lab’s president and CEO, said the deal “marks a turning point for biomedical research” that combines the lab’s expertise in genetics and mouse models with the foundation’s stem cell and automation technologies. Together, he said, the capabilities will create a platform that accelerates early-stage biomedical research that could uncover disease mechanisms earlier and advance progress toward therapies for diseases such as Alzheimer’s, cancer, diabetes, Parkinson’s and rare diseases. The deal unites the lab’s strengths in mouse genetics and disease research with the foundation’s stem cell...